Virginia Regulatory Town Hall
Agency
Department of Health Professions
 
Board
Board of Optometry
 
chapter
Regulations of the Virginia Board of Optometry [18 VAC 105 ‑ 20]
 
Action is Exempt from Article 2 of the Administrative Process Act
Action:
Addition of alpha-adrenergic agonists to TPA formulary
Action 5622 / Stage 9092
Proposed Stage  
Documents
red ball Proposed Text 9/28/2020  11:06 am  
pdf Agency Background Document 9/28/2020    

Status
Attorney General Review For some stages the Attorney General review is optional
Virginia Registrar Submitted on 9/28/2020
 
The Virginia Register of Regulations
 
Publication Date: 10/12/2020    Volume: 37  Issue: 4
Comment Period No comment period held for this exempt action/stage.
 
Contact Information
Name / Title: Leslie L. Knachel  / Executive Director
Address: 9960 Mayland Drive
Suite 300
Henrico, VA 23233
Email Address: leslie.knachel@dhp.virginia.gov
Telephone: (804)597-4130    FAX: (804)793-9145    TDD: ()-
 
This person is the primary contact for this board.

query.....


X
close window 
After uploading your memo document, don't forget to submit your review
Submit Review
X
close window 
Action 5622:
Addition of alpha-adrenergic agonists to TPA formulary
 
Stages associated with this regulatory action.
Stage Type Status
Proposed   (9092) Stage complete. No comment period held.
Final   (9112) Stage complete. This regulation became effective on 12/09/2020.
X
close window 
Place On Hold Pending External Action
Enter a reason up to 300 characters. Will be viewable only on the Governor's Pending List.

and return to view the Pending List
A stage can be placed "On Hold" only once. When there are major issues with a stage, please consider asking the agency to withdraw the stage and submit a new stage when it is ready for review.